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Two strains of White Leghom hens selected for high (HA) or low (LA) 
antibody response to challenge with sheep red blood cells were used to determine 
differences in circulating levels of progesterone (P 4) and luteinizing hormone 
(LH), and to determine in vitro effects of tumor necrosis factor alpha (TNF a) on 
granulosa cell steroid secretion during different periods of the estrous cycle. In 
experiment one, hens were serially bled from 4 hours after oviposition until the 
next oviposition. Plasma was analyzed for P 4 and LH using validated 
radioimmunoassays (RIA's). In the second experiment, hens were sacrificed at 16 
and 37 weeks of egg production. Granulosa cells isolated from the F1, F2, and F3 
follicles were incubated for 3 hours in the presence of; 1) untreated RPMI 1640 + 
0.1% bovine serum albumin + 1% antibiotics (control) 2) 5 ng/ml human 
recombinant TNFa (hTNFa) 3) 5 ng/ml murine recombinant TNFa (mTNFa) 4) 
100 ng/ml ovine LH (oLH) 5) hTNFa plus oLH 6) mTNFa plus oLH. 
Conditioned media was analyzed for P 4 and P 5 secretion as before. 
Plasma levels of both P 4 and LH were significantly higher (P~0.05) among 
HA hens during the peak preovulatory period of the estrous cycle (-6 to -1 hours 
before oviposition). Circulating levels of P4 were 1.45, 2.19, 2.67, 2.66, and 2.38 
ng/ml in LA hens versus 1.82, 3.05, 3.19, 3.07, 3.01, and 2.79 ng/ml respectively 
in HA hens at 6, 5, 4, 3, 2, and 1 hour prior to oviposition. Levels of LH were 
2.36, 3.36, 3.57, 2.81, 2.41, and 1.95 ng/ml in LA hens versus 3.58, 5.27, 5.38, 
4.51, 3.77, and 3.71 ng/ml respectively in HA hens for the same period. 
As with plasma, granulosa cells from HA hens produced more (P~0.05) P4 
and P5 than did those from LA hens. Similarly, granulosa cells from larger 
follicles secreted more (P~0.05) P4 and P5 than did those from smaller follicles. 
Treatment of granulosa cells with human, but not murine, TNFa reduced (P~0.05) 
Vll 
basal P 4 and P5 production by granulosa cells from preovulatory follicles. 
Conversely, treatment of cells with oLH significantly increased (P~0.05) P4 and P5 
as compared to controls. The combination of mTNFa., but not h1NFa., and oLH 
consistently stimulated (P~0.05) P4 and P5 secretion above that observed with 
treatment of oLH alone. Mouse 1NF a. is known to activate both type I and type II 
1NFa. receptors, while h1NFa. binds only the type I receptor. This may explain 
the differential effects on in vitro steroid secretion observed through use of the two 
forms of 1NFa. in these experiments. Furthermore, the observation that h1NFa. 
and oLH rarely caused significant increases, but frequently caused numerical 
increases in P 4 and P 5 secretion is suggestive of a ligand passing role for the type II 
receptor. No clear pattern emerged as to when during the estrous cycle h1NFa. 
affected steroid production. In the avian, reduced steroidogenic capacity 
(specifically, the production of progesterone) can lead to delayed or inhibited 
ovulation. Results from these experiments suggest a potential role for human 
and/or murine 1NFa. in reproduction in the laying hen (Gallus domesticus). 
Vlll 
1. LITERATURE REVIEW 
Cytokines are a group of 6,000 - 60,000 kiloDalton (kDa) proteins, of 
which over thirty have been isolated since their discovery in the early 
1970's (Rafael and Orvieto, 1992). These proteins are derived from 
activated immune cells and are involved in cell-to-cell communication, 
resulting in initiation of the immune response, inflammatory reactions, and 
hematopoiesis (Dinarello and Mier, 1987). These pleiotropic peptides are 
also potent regulatory factors. Unlike hormones, which are usually 
produced at a specific locus and act systemically, cytokines are produced by 
a wide variety of cells and act in an autocrine, paracrine, or endocrine 
fashion (Klasing and Johnstone, 1991). Cytokines can be further 
subgrouped into interleukins, lymphokines, and monokines. The term 
interleukin refers to soluble factors which mediate communication between 
leukocytes, while lymphokines and monokines designate cytokines which 
are produced by lymphocyte and monocyte/macrophage cells respectively 
(Rafael and Orvieto, 1992). As more information is compiled concerning 
their source and function, it is apparent that many cytokines fall into more 
than one of these subgroupings. 
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Tumor necrosis factor alpha (TNFa) is a potent monokine that was 
discovered in 1975 in an attempt to identify a protein involved in tumor 
cytotoxicity (Carswell et al., 1975). TNFa is also referred to as "cachectin" 
for its involvement in the phenomenon of wasting, and "necrosin" for its 
ability to cause cell death (Beutler and Cerami, 1986). TNFa is classified 
as a type II membrane protein which is characterized by a C-terminus in the 
extracellular domain. Other type II membrane proteins include; TNFP 
(lymphotoxin), Fas ligand, OX40 ligand, Chain of Differentiation (CD) 40 
ligand, CD27 ligand, CD30 ligand, and lymphotoxin p (Gruss and Dower, 
1995). Structurally, TNFa is a 26 kDa membrane bound protein which has 
a 29 amino acid (aa) cytoplasmic tail, a 28 aa transmembrane region, and a 
176 aa extracellular domain (Gruss and Dower, 1995). Proteolytic cleavage 
of the membrane bound protein by TNFa converting enzyme (TACE) 
results in the release of a 1 7.4 kDa, 157 aa soluble protein as a homotrimer 
with a three dimensional structure similar to the "jelly roll" motif shared by 
various viral capsids (Kreigler et al., 1988; Brannstrom et al., 1993; Black 
et al., 1997). 1NFa. is expressed by many cell types including macrophage, 
CD4+ and CD8+ thymocyte (T) cells, keratinocytes, adipocytes, kidney 
tubule epithelial cells, splenocytes, astrocytes, pancreatic P-cells, neurons, 
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and osteoblasts (Hunt et al., 1992; Ware et al., 1992; Lee et al., 1993; 
Yamada et al., 1993; Kern et al., 1995; Lisby et al., 1995; Modrowski et 
al., 1995; Villarroya et al.,1997). Due to the wide variety of cells which 
express TNFcx, it is more practical to list those cell types in which this 
cytokine is not expressed or has yet to be identified. These include 
erythrocytes and resting T cells which do not express the protein nor its 
receptors (Fiers, 1991). Both human and mouse TNFcx have been cloned 
and exhibit approximately 79% amino acid sequence homology (Fransen et 
al., 1985; Pennica et al., 1985). Experimental evidence suggests that 
normal circulating levels of TNFcx are between 10 and 80 pg/ml 
(Steinshamn et al., 1995; Spengler et al., 1996). Beutler et al. (1985) 
determined the half-life of TNFcx in plasma to be approximately six 
minutes. 
To date, two TNF ex receptors have been identified, type I and type II. 
Both receptors belong to the TNFcx/nerve growth factor receptor (NGFR) 
superfamily and share 28% sequence homology in their extracellular 
domains (Tartaglia et al., 1993). Their intracellular domains, however, 
apparently share no sequence homology, suggesting the use of different 
signaling pathways (Lewis et al., 1991 ). The TNF ex receptors are classified 
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as type I membrane proteins characterized by 4 cysteine-rich motifs in the 
extracellular binding domain (Baker and Reddy, 1996). Both receptors can 
be released as soluble proteins, via proteolytic cleavage of their extracellular 
domains. Soluble receptors have been identified in the serum and urine of 
normal and diseased patients (Spengler et al., 1996; Olsson et al., 1989). 
Physiologically, soluble receptors may act to inhibit 1NFa. activity, as 
cleavage of the extracellular domain reduces the number of cell surface 
receptors. Soluble receptors may also bind to soluble 1NFa., thereby further 
reducing concentrations of the cytokine available for receptor binding at the 
cell surface. 
The type I TNFa. receptor has a molecular weight of 55 kDa, and is 
designated TNF-Rl, 1NF-R55, p55, or CD120a (Fiers,1991). This 
glycoprotein, consisting of a 190 aa extracellular region, a 25 aa 
transmembrane segment, and a 220 aa cytoplasmic domain, binds to the 
human and murine forms of TNFa. with equal affinities (Gruss and Dower, 
1995; Lewis et al., 1991). Studies utilizing monoclonal and polyclonal 
antibodies directed against TNF-Rl identify it as the receptor responsible 
for the majority of actions associated with TNFa.. These studies implicate 
the type I receptor in cytotoxicity, fibroblast proliferation, resistance to 
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Chlamydia trachomatis, antiviral activity, and synthesis of prostaglandin E2 
(Englemann et al., 1990; Espevik et al., 1990; Shalaby et al., 1990; Wong et 
al., 1992). Tartaglia et al. (1993) identified a region of approximately 80 
aa's within the intracellular domain of the type I receptor that is responsible 
for initiating the signal for cytotoxicity. 
The type II TNFa receptor has a molecular weight of 75 kDa and is 
referred to as TNF-R2, TNF-R75, p75, or CD120b (Fiers, 1991). This 
glycoprotein consists of a 240 aa extracellular domain, a 27 aa 
transmembrane segment, and a 173 aa cytoplasmic domain (Gruss and 
Dower, 1995). The larger, type II receptor exhibits a 5 fold greater affinity 
for TNFa than does the type I receptor (Barbara et al., 1994). Unlike TNF-
Rl which binds to both human and murine TNFa, the type II receptor binds 
only to murine TNFa (Lewis et al., 1991). Monoclonal and polyclonal 
antibody studies reveal that activation of this receptor stimulates 
proliferation of primary thymocytes and cytotoxic T-cells (Sheehan et al., 
1995; Tartaglia et al., 1991). 
Biological effects of TNFa on various cells and tissues have been 
studied extensively. TNFa blocks the synthesis of triglycerides while 
concurrently stimulating adipocytes to release current stores into the plasma, 
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thus implicating TNF a in the phenomenon known as "wasting" (Beutler and 
Cerami, 1988). Complicating this already dangerous pathological state, 
TNF a activates osteoclasts causing the subsequent resorption of bone 
(Bertolini et al., 1986). Furthermore, Garrett et al. (1987) showed that 
TNFa inhibited cartilage synthesis while promoting proteoglycan break-
down. 
In addition to its involvement in cachexia, TNFa is thought to be 
responsible for many of the symptoms which accompany endotoxic shock, 
including; fever, hypotension, diarrhea, metabolic acidosis, and in severe 
cases, death (Beutler and Cerami, 1986). TNFa has also been observed to 
cause fever by inducing hypothalamic neurons to produce prostaglandin E2 
(PGE2) (Dinarello et al., 1986). 
However, TNFa is best known for its involvement in the 
inflammatory reaction of the immune response. TNF a enhances immune 
responses via activation of neutrophils and eosinophils (Silberstein et al., 
1986). Neutrophil adhesion, phagocytosis, and complement receptors are 
reportedly increased upon exposure to TNFa (Shalaby et al., 1985; 
Klebanoff et al., 1986; Berger et al., 1988). The proposal that ovulation is 
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akin to an inflammatory reaction suggests the possibility that cytokines may 
play a role in reproductive function (Espey, 1980). 
Several studies have indicated the presence ofTNFa within the ovary 
of various species. Using immunocytochemistry, immunoreactive TNFa 
has been localized in oocyte, granulosa, and mononuclear cells within the 
ovaries of the mouse and rat (Chen et al., 1993; Marcinkiewicz et al., 1994; 
Roby and Terranova, 1989). In humans, immunoreactive TNFa has been 
identified in granulosa, luteal, and paraluteal cells of the ovary (Roby et al., 
1990). Evidence also exists for biologically active TNFa in cumulus cells 
of the oocyte in the human, as well as follicular fluid in the human and 
bovine (Zolti et al., 1990; Zolti et al., 1991; Wang et al., 1992; Jasper and 
Norman, 1995). Naylor et al. (1990; 1993) determined the presence of 
TNF a mRNA in human thecal cells via in situ techniques. In the corpus 
luteum, TNFa has been identified in endothelial cells and large luteal cells 
of swine (Hehnke-Vagnoni et al., 1995; Wuttke et al., 1993). Similarly, 
TNFa has been identified in the corpus luteum of the rabbit, sheep, and cow 
(Bavangados et al., 1988; 1990; Ji et al., 1991; Shaw and Britt, 1995). 
Although the presence of TNF a in these tissues is readily accepted, 
its origin remains to be elucidated. Bagavandoss et al. (1990) proposed that 
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the pnmary source of TNFa was from extraovarian white blood cells 
infiltrating the ovary; while others suggest that TNFa may be derived from 
cells resident in the ovary itself (Sancho-Tello et al., 1992). The findings by 
Zolti et al. (1990) that human granulosa cells are both a source and target 
for TNFa lend credence to the theory that there is an intraovarian source of 
TNFa, and that it may play a role in the reproductive cycle. 
In the growing mammalian follicle, granulosa cells are responsible for 
the production of estrogen, as well as a small amount of progesterone. In 
several studies, TNF a has been shown to suppress either aromatase or 
estradiol production by granulosa cells. Emoto and Baird (1988) reported 
that in cultured rat granulosa cells, 10 pg/ml - 1 Ong/ml TNFa suppressed 
aromatase activity in the presence of 250 ng/ml follicle stimulating hormone 
(FSH). This dose-dependent response culminated in the total abolition of 
FSH induced aromatase activity at 10 ng/ml TNF a. A time-course study 
revealed that TNFa did not inhibit the activity of the existing enzyme, but 
rather, blocked any subsequent induction of aromatase activity by FSH. 
Similarly, Adashi et al. (1990) showed a significant reduction in FSH 
induced estradiol production in rat granulosa cells (10 ng/ml TNFa). In 
small human and bovine follicles, TNFa inhibited FSH induced aromatase 
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activity and estradiol production by granulosa cells (Montgomery et al., 
1996; Spicer and Alpizar, 1994). Furthermore, TNFa (0.1-100 ng/ml) was 
shown to reduce FSH induced LH receptor formation in cultured rat 
granulosa cells, with an almost complete inhibition at 50 ng/ml (Darbon et 
al., 1989). Taken together, these findings suggest a possible role for TNFa 
in modulation of granulosa cell differentiation. 
In response to an LH surge, mammalian granulosa cells luteinize to 
become granulosa-luteal cells, and eventually, either small or large luteal 
cells of the corpus luteum. These cells are responsible for the increased 
progesterone production associated with the luteal phase of the estrous cycle 
and pregnancy. Adashi et al. (1990) reported that TNFa (10 ng/ml) caused 
significant inhibition of FSH stimulated (100 ng/ml) progesterone 
production in granulosa-luteal cells of the rat. Similarly, TNFa caused 
decreased production of progesterone in response to LH, oxytocin, and 
forskolin in the small luteal cells of swine (Richards and Almonds, 1994; 
Wuttke et al., 1993). 1NFa reportedly increased the production of 
prostaglandins, specifically PGF2a, in luteal cells of the human and bovine, 
as well as in luteinized granulosa luteal cells in the human (Wang et al., 
1992; Zolti et al. 1990; Benyo and Pate, 1992). The ability of TNFa to 
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inhibit gonadotropin induced progesterone production, while stimulating 
that of prostaglandins, suggests a luteotlytic role for the cytokine (Pate, 
1995). 
In mammals, the granulosa cell layer is responsible for the 
production of estrogens, whereas the theca layer contains androgen and 
progesterone producing cells. Roby and Terranova ( 1990) found that basal 
and FSH induced progesterone were inhibited by TNFa in rat granulosa-
luteal cells, however, in cultured whole follicles (theca included) under the 
same conditions, progesterone production was actually increased by TNFa., 
with a concurrent increase in androgen production by the theca cells (Roby 
and Terranova, 1990). This implies the possibility that the effects of TNFa. 
on steroid production in isolated granulosa cells may be very different from 
its effects on granulosa cells co-cultured with theca cells. Conversely, in 
the rat, TNF a caused a dose-dependent inhibition of human chorionic 
gonadotropin-stimulated androsterone and androstenedione production in 
whole ovarian dispersates (Andreani et al., 1991; Zachow et al., 1992). In 
theca cells of the pig, TNFa. caused a dose-dependent inhibition of LH 
stimulated progesterone at concentrations of between 0.1 and 100 ng/ml 
(Tekpetey et al., 1993). Interestingly, TNFa. has been shown to induce 
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clustering of theca-interstitial cells of the rat (Zachow et al., 1992). It has 
therefore been suggested that TNF a may play some role in the early 
organization of follicular cells (granulosa and/or theca) around the oocyte 
(Terranova et al., 1995). 
While the effects of TNFa on ovarian steroidogenesis may be 
apparent, the mechanism(s) by which they are brought about are not. 
Adashi et al. (1989) ruled out the possibility that the inhibitive action of 
TNFa on granulosa cell steroidogenesis is a lasting nonspecific effect due 
to its cytotoxicity. TNFa does not significantly reduce cell number, DNA 
content, or viability, and the effects of TNFa are reversed upon removal of 
the cytokine (Adashi et al., 1989). These data suggested that TNFa directly 
and specifically regulates steroidogenesis. Luteinizing hormone receptor 
numbers are reportedly reduced by TNFa in the follicular cells of the rat 
(Darbon et al., 1989). Tumor necrosis factor a. has been reported to inhibit 
LH induced cAMP accumulation in theca and granulosa cells of the pig and 
rat (Tekpetey et al., 1993; Veldhuis et al., 1991; Zachow et al., 1992; Emoto 
and Baird, 1988). Zachow et al. ( 1993) found that in addition to LH 
receptors and cAMP, TNF a directly inhibited protein kinase A. Tumor 
necrosis factor a also inhibited the activities of P450 side chain cleavage 
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(P 4soscc) and 3 f3-hydroxysteroid dehydrogenase enzymes, as well as the 
expression of cytochrome P 4soscc mRNA in swine (Veldhuis et al. 1991 ). 
Logically, one might assume the TNFa has the same effect on ovarian 
steroidogenesis in the avian as that in the mammal. However, the avian 
ovary differs from mammalian ovaries in a number of important ways. 
Initially, both left and right ovaries and oviducts are present in embryonic 
hens. However, shortly after hatching, the right ovary regresses in response 
to an unknown factor( s) secreted by the left ovary (Marrone and Hertendy, 
1983 ). The majority of follicles on the ovary of the hen are small white or 
small yellow follicles (SWF's or SYF's) with diameters between 1 and 8 
millimeters (mm; Armstrong, 1985). The larger (>8mm diameter), yolk-
filled follicles, which are attached to the ovary by follicular stalks, are 
arranged in a hierarchy based on size (Bahr and Nalbanov, 1977). The 
largest of these five or six pre-ovulatory follicles (F 1, F2, ••• F6) will be the 
next to ovulate (Gilbert, 1971). When the largest follicle (F1) ovulates, the 
former F 2 follicle moves up in the hierarchy (becoming the F 1 follicle), as do 
all other pre-ovulatory follicles. Unlike mammals, there is no corpus luteum 
(CL) formation following ovulation in the hen. However, the biggest 
difference is that granulosa cell progesterone is the predominant hormone 
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driving the avian cycle, rather than estrogen as in the mammal. These 
differences suggest that the role played by TNFa in reproductive function 
(if any) may be quite different for avian species. 
As the follicle matures, the great increase in size is accompanied by 
changes in steroidogenic function. Small white follicles are the major 
source of estrogen in the hen (Armstrong, 1984). While the largest pre-
ovulatory follicle (F 1) is known to be responsible for the majority of 
progesterone produced in the hen ovary, some contribution is made by the 
smaller pre-ovulatory follicles (Fi-F 4; Huang et al., 1979). These 
differences are due to changes in granulosa and theca cell physiology as the 
follicle matures. 
Each follicle on an avian ovary consists primarily of two cell layers. 
The innermost layer made up of granulosa cells which surround the yolk 
and ovum of the follicle. The theca layer, which is highly vascularized and 
innervated, is located immediately outside and adjacent to the granulosa 
layer (Hodges, 1974). The two layers are, however, physically separated by 
the basement membrane. As stated previously, small follicles are 
responsible for the majority of estrogen produced in the ovary. This 
estrogen is produced solely by the theca layer, as the granulosa cells of 
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small follicles are steroidogenically incompetent (Davidson et al., 1979). 
The inability of granulosa cells from small follicles to produce steroids is 
due to the inactivity of the 17 a.-hydroxylase and C 1 7 ,20 lyase enzymes 
(Tilly et al., 1991). When the follicle reaches 2 - 4 mm in diameter, the 
theca layer differentiates into theca intema and theca extema cells (Nitta et 
al., 1991). As the follicle approaches ovulation, enzyme activity (aromatase 
and 3 f3-hydroxy-~5-steroid dehydrogenase) in the theca layer decreases, 
culminating in the complete cessation of steroidogenic capacity in the theca 
cells of F 1 follicles (Huang et al., 1979; Armstrong, 1982). It is not until the 
follicle reaches 9 - 12 mm in diameter that its granulosa cells are capable of 
producing progesterone. Furthermore, although LH receptors are present on 
smaller follicles, granulosa cells will not respond to LH until the follicle is 
12 - 15 mm in diameter (Tilly et al., 1991). 
Currently, there are two theories that have been proposed to describe 
the steroidogenic events that take place in the avian ovary. Huang et al. 
( 1979) proposed a two-cell model of follicular steroidogenesis which 
assumes that the theca layer is uniform in its steroidogenic function. This 
theory proposes that the majority of progestin production, as well as a small 
amount of androgen synthesis, is derived from the granulosa cells of pre-
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ovulatory follicles. Progestins are secreted by granulosa cells and then 
further metabolized to androgens and estrogens in theca cells (Huang et al., 
1979). The more recent, three-cell theory of avian steroidogenesis proposes 
that progesterone produced in granulosa cells is metabolized by two distinct 
theca cell types (Porter et al., 1989). In this model, theca intema cells 
utilize progesterone derived from granulosa cells to produce androgens, 
which are then passed to theca extema and converted to estrogens (Porter et 
al., 1989). There has been very little research directed at the role of 
cytokines on reproduction in avians. Bryan et al. ( 1997) reported that 
human recombinant TNF a at a dose of 5 ng/ml consistently inhibited in 
vitro progesterone production among granulosa cells in the F 1, F 2, and F 3 (3 
largest) follicles of the hen. 
Advances in the field of genetics have given researchers new tools to 
aid in the study of reproductive function in the avian. Gross (1979) and 
Siegel and Gross (1980) developed two genetic lines of White Leghorn 
chickens selected for their ability to respond to an immune challenge after 
an injection of sheep red blood cells (SRBC). Birds in which high levels of 
antibodies were persistent five days after SRBC injection were termed high 
antibody (HA), while those with low levels were called low antibody (LA). 
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Using these two distinct lines, research has been conducted to determine 
whether the degree of antibody production effects the ability of a bird to 
resist bacterial and viral challenges. Both Hall et al. ( 1978) and Gross et al. 
(1980) found that the LA line exhibited a greater susceptibility to infection 
by Mycoplasma gallisepticum, coccidiosis, splenomeglia virus, New Castle 
Disease, and the northern fowl mite than did the HA line. Susceptibility to 
Esherichia coli and Staphylococcus aureus infection, however, was 
significantly greater in the HA line (Dunnington et al., 1991 and Gross et 
al., 1980). Gross et al. ( 1980) reported a 58% incidence of E. coli in the 
HA line compared to 3 5% for the LA line after inoculation of the posterior 
air sac with 10·3 to 10-4 cells. Similar results were reported in mice selected 
for low and high antibody response to SRBC (Biozzi et al., 1979). These 
results suggest that strong antibody response is negatively correlated with 
the ability to defend against bacterial infection. The mechanisms by which 
birds defend themselves against invasion and infection may determine 
degree of resistance or susceptibility to specific diseases. 
Differences in egg production characteristics between the LA and HA 
lines have also been reported. Siegel et al. (1982) found that hen-day egg 
production to 300 days was significantly lower in the HA line as compared 
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to the LA line. LA birds began egg production at an earlier age and at lower 
body weights than did HA birds (Siegel et al., 1982 and Martin et al., 1990). 
Martin et. al. (1990) reported higher body weights for LA birds as measured 
at 4 and 24 weeks of age. Fertility was also different between the two lines 
with HA birds exhibiting reduced fertility at all ages (Seigel et. al., 1982). 
The differences in weight gain, egg production, age of sexual 
maturity, and response to an immune challenge in these two lines imply that 
immuno-competence and reproductive function may somehow be related. 
The objectives of the following study were to: 1) determine the differences 
in plasma levels of P 4 and LH between HA and LA hens, 2) determine the 
effect of human versus murine TNFa. on granulosa cell P4 and P5 secretion 
among HA and LA lines of hens, and 3) determine the differences in P 4 and 
P 5 production by granulosa cells during the ovulatory cycle as affected by 
human and murine TNF a. in the presence of an ovulatory amount of ovine 
LH. By studying these parameters, it may be possible to gain a better 
understanding of the relationship between immune status and reproductive 
function in the domestic laying hen ( Gallus domesticus ). 
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2. MATERIALS AND METHODS 
One hundred and twenty Single Comb White Leghorn hens selected 
for a high (HA) or low antibody (LA) response to immuno-challenge with 
sheep red blood cells (SRBC) were housed in individual cages at Cherokee 
Poultry Farm, University of Tennessee at Knoxville. Hens were allowed ad 
libitum access to feed and water on a lighting schedule consisting of 16 
hours of light and 8 hours of darkness. Hens were fed a standard 
commercial poultry layer mash which contained 16% protein (Tennessee 
Farmers CO-OP, Lavergne, TN). Egg records were maintained from hatch 
to 442 days of age and were updated daily in order to determine hen-day 
egg production (HDEP). Percent HDEP was defined as the percentage of 
eggs laid ( egg production) in a given time period per number of live hens 
during that same period (hen-days; North, 1978). For example, if 4 hens 
produced 9 eggs in 3 days and none died, percent HDEP for the hens in 
those 3 days was 75% (9 eggs/(4hens)(3days) X 100 = 75). Data collection 
began when flock HDEP reached 15% for each line. Experiment 1 was 
conducted to determine in vivo levels of circulating steroids in HA and LA 
hens during one ovulatory cycle. A second experiment was conducted to 
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determine in vitro steroid production of granulosa cells from HA and LA 
hens as affected by 1NF ex.. 
Experiment 1 
At 14 and 34 weeks of egg production, hens were monitored for time 
of oviposition and serially bled via brachia! vein cannulation as described 
by Johnson (1981) at 4, 8, 12, and 16 hours after oviposition, and 
subsequently every hour until the next oviposition. This timeline was 
reversed in order to reflect hours before oviposition. Three mis of blood 
was collected from each hen and centrifuged at 400 X g for 10 minutes in 
order to separate plasma from erythrocytes. Plasma was decanted into 12 x 
75 mm borosilicate glass tubes (Fisher Scientific, Pittsburgh, PA) 
containing 50 ul saturated sodium citrate (Baxter, McGraw Park, IL) and 
stored at -20°C for later analysis. Hematocrits were determined every 3rd 
sample to ensure that packed cell volume did not drop more than 20% 
below baseline, which was determined at the time the cannula was seated. 
Erythrocytes were kept separate by hen, pooled, and combined with an 
equal volume of 0.9% saline and 50,000 U penicillin G (Sigma, St. Louis, 
MO). Erythrocytes were returned to the hen after every 3rd blood sample to 
maintain blood volume. Plasma was analyzed for progesterone (P4) using 
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a validated (Bryan et. al., 1997) commercially available radioimmunoassay 
kit (Diagnostic Products Corp., Los Angeles, CA). Luteinizing hormone 
(LH) was measured by radioimmunoassay using specific antisera to 
chicken LH (USDA-AcLH-5), reference standards (USDA-cLH-K-3), and 
immuno-chemical grade hormone for radioiodination (USDA-cLH-I-3) 
according to the procedure of Johnson and van Tienhoven (1980). 
Experiment 2 
At 16 and 37 weeks of egg production, 5 birds from each line were 
sacrificed at 4, 12, 18, 24 hours post oviposition of a mid sequence egg. 
The ovary was removed from each hen, washed in Hank's basal salt 
solution (Gibco, Grand Island, N.Y.), 70% ethyl alcohol, and again in 
Hank's before storage in RPMI-1640 on ice. Ovaries were blotted dry and 
weighed. Follicles were measured (mm diameter), counted, and sorted by 
size (F1, F2, F3, 10-12 mm, 7-9 mm, 4-6 mm, and 1-3 mm). Atretic 
follicles, determined as those deflated or in a hemorrhaged state (Tilly et. 
al. 1991 ), were also counted. Upon removal of connective tissue and 
vasculature surrounding the three largest follicles (F 1, F 2, and F 3), the 
granulosa layer was microdissected from the theca layer using aseptic 
techniques. Granulosa layers from the three largest follicles of each hen 
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were pooled according to size, and individual cells isolated via digestion in 
a 2.5 mg/ml trypsin (Sigma, St. Louis , MO)/Hank's basal salt solution 
under constant agitation for 3 minutes at 3 7°C. Granulosa cells were 
centrifuged at 400 X g for 4 minutes and washed twice with RPMI-1640 
(Gibco, Grand Island, NY). Cells were counted by trypan blue dye 
exclusion and plated at a concentration of 500,000 cells/0.5 ml in RPMI-
1640 media, antibiotics (50 U penicillin, 50 ng/ml streptomycin, and 100 
ng/ml neomycin), and 0.1 % bovine serum albumin (Sigma, St. Louis, 
MO; hereafter called complete media). Treatments consisted of; 1) 
untreated media (control), 2) 5 ng/ml human recombinant TNFa (hTNFa; 
R&D Systems, Minneapolis, MN), 3) 5 ng/ml murine recombinant TNFa 
(mTNFa; R&D Systems), 4) 100 ng/ml ovine LH (oLH; National Institute 
of Arthritis, Diabetes and Digestive and Kidney Diseases, Bethesda, MD), 
5) hTNFa + oLH, or 6) mTNFa + oLH. Cells and their respective 
treatments were cultured for 3 hours in 95% air and 5% CO2 at 39.5 °C. 
After incubation, cells were pelletted, the supernatant removed and stored 
in 12 x 75 borosilicate glass tubes at -20 °C for later analysis. Progesterone 
(P 4) secretion by granulosa cells was measured using the commercial RIA 
described previously (Bryan et al., 1997). Pregnenolone (P5) secretion by 
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granulosa cells was measured via radioimmunoassay and validated using 
antisera to pregnenolone-3 hemisuccinate (Accurate Chemical and 
Scientific Corp., Westbury, NY) and radio labeled 7-3H(N) pregnenolone 
(21.0 Ci/mmol; New England Nuclear, Boston, MA). The antiserum is 
known to cross-react with 17-hydroxypregnenolone ( 1.0% ), progesterone 
(3.0%), 17-hydroxy-progesterone (1.4%), corticosterone (<0.4%), 11-
deoxycorticosterone (<0.3%), cortisol (<0.3%), 11-deoxycortisol (<0.3%), 
5~-pregnan-3,20 dione (<0.4%), 5a-pregnan-3,20 dione (4.5%), 5a-
pregnan-3a01,20 one (5.6%), 5a-pregnan-3a,20a diol (<0.45%), and 5a-
pregnan-3 ~,20 diol ( <0.4%; Accurate Scientific and Chemical Corp., 
Westbury, NY). Reagents were diluted in 0.05 M sodium phosphate buffer 
containing 0.1 % gelatin and 0.2% sodium azide, pH 7.4 (hereafter call 
reaction buffer). Into 12 x 75 mm glass borosilicate tubes were added 400 
µl reaction buffer, 100 µl antiserum (1:23,000 dilution), 100 µl 3H-P5 
(10,000 cpm), and 100 µl standard or unknown. Standards (15.625 pg/ml -
4.0 ng/ml) were made by adding specific quantities of 5-pregnen-3 ~-ol-20-
one (Steraloids Inc., Newport, RI) to reaction buffer. Reaction mixtures 
were incubated for 30 minutes at 37°C, and then for 16 hours at 4°C. After 
incubation, 500 µls of 1: 10 Dextran-T70/Norit A (Fisher Scientific, 
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Pittsburgh, PA) charcoal solution was added to each sample tube. Samples 
were held at 4°C for 10 minutes, and then centrifuged at 1,500 X g and 4°C 
(Beckman TJ-6; Fullerton, CA) for 15 minutes. Supematants were 
decanted into 50 x 16 mm scintillation vials (Sarstedt, Newton, NC), mixed 
with 5 mls UltimaGold™ scintillation fluid (Packard, Downers Grove, IL), 
and counted in a liquid scintillation counter (Beckman LS5801, Fullerton, 
CA). Tests for parallelism were conducted using 35, 45, and 55 ul of 
media pooled from the 3 largest preovulatory follicles (Table 1 ). The 
optimal dilution of pregnenolone antiserum was determined to be 1/23,000 
which agreed with the dilution suggested by the manufacturer (Table 2). 
Intra- and Inter-assay coefficients of variation for the assays were 5 .2 and 
11.6%, and 7.7 and 8.9% for P4 and P5, respectively. 
Data Analysis 
Data were analyzed using the Mixed procedure of the statistical 
analysis system (SAS, 1996). Data were log transformed prior to analysis 
to determine significance. Means were separated by Fisher's least 
significant difference test. Table values are reported as the least square 
(LS) mean of the non-log transformed data with significance denoted at 
P<0.05. 
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*Final dilution according to the manufacturer's instructions (Accurate Scientific and 




Hens from the LA line reached puberty (first egg) and 15% HDEP 
earlier than did hens from the HA line (150 and 163 days of age versus 158 
and 172 days of age, respectively). Because of this difference in 
reproductive age, LA hens were killed approximately 9 days prior to HA 
hens during in vitro experiments in order to maintain differences due to 
physiological age. Overall percent HDEP between the HA and LA lines 
(66.62 and 63.47%, respectively) did not differ significantly (P>0.05). 
However, if percent HDEP was measured from the day of first egg ( day 
150) to 442 days of age ( cessation of the experiment), LA hens laid at a 
higher rate (P<0.05), 64.53 versus 58.82%, respectively. 
At both 16 and 3 7 weeks of egg production, ovary weight from HA 
hens was greater (P<0.05) than that of LA hens (Table 3). In younger hens, 
the size of FI and F3 follicles was not different between lines (P>0.05). 
There was also no difference in either the number of small, slowly growing 
(1-12 mm) or atretic follicles among hens from either genetic line (Table 4). 
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Table 3. Ovary weight and size of F 1, F 2, and F 3 follicles for HA and LA 
hens at 16 and 37 weeks of egg production*. 
Weeks of Egg Production 
li II. 
Follicle Weight, 
Size, or Number 
Genetic Line/(number of hens) Genetic Line/(number of hens) 
HA/(n=20) LA/(n=20) HA/(n=20) LA/(n=20) 





33.58 ± 0.33 8 
29.97 ± 0.43 8 
25.47 ± 0.61 AB 
32.90 ± 0.33 B 
28.50 ± 0.40 C 
24.15 ± 0.58 BC 
35.19 ± 0.35 A 
32.03 ± 0.45 A 
26.47 ± 0.63 A 
*Values are reported as least square means± standard error of the mean. 
t A,B,CValues in the same row with different letters are significantly different (P :s; 0.05). 
!Millimeters diameter. 
33.71 ± 0.33 8 
29.76 ± 0.41 8 
23.18 ± 0.60 C 
Table 4. Numbers of 10 - 12 mm, 7- 9 mm, 4 - 6 mm, 1 - 3 mm, and atretic 
follicles for HA and LA hens at 16 and 37 weeks of egg production*. 
Weeks of Egg Production 
16 II. 
Genetic Line/(number of hens) Genetic Line/(number of hens) 
Number of Follicles HA/(n=20) LA/(n=20) HA/(n=20) 
10 - 12 mm (No. t) l.21±0.17At 1.00 ± 0.17 A 1.06 ± 0.18 A 
7-9 mm (No) 4.00 ± 0.67A 5.30 ± 0.66 A 5.88 ± 0.71 A 
4-6 mm (No.) 13.00 ± 1.07 AB 11.75 ± 1.04 8 15.35 ± 1.13 A 
1-3 mm (No.) 26.32 ± 2.19 8 25.80 ± 2.13 8 38.06 ± 2.31 A 
Atretic Follicles 4.32 ± 0.56 AB 4.05 ± 0.54 8 5.71 ± 0.59 A 
*Values are reported as least square means± standard error of the mean. 
t Number ofFollicles 
;A,B,C Values in the same row with different letters are significantly different (P :s; 0.05). 
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LA/(n=20) 
0.88 ± 0.17 A 
5.84 ± 0.67 A 
11.16 ± 1.07 8 
28.47 ± 2.10 8 
5.16 ± 0.56 AB 
At 37 weeks of egg production, all pre-ovulatory follicles (F1•3) were 
larger (P<0.05) among HA hens as compared to LA hens. Similarly, there 
were more (P<0.05) 1-3 and 4-6 mm small white follicles among older HA 
hens, but not of 7-9 mm, 10-12 mm, or atretic follicles between lines. 
In Vivo Steroid Secretion 
Both plasma progesterone and luteinizing hormone were significantly 
higher (P<0.05) among HA versus LA hens during the peak pre-ovulatory 
period of the ovulatory cycle (Figures 1 and 2). Specifically, circulating 
levels of progesterone (Figure 1) and luteinizing hormone (Figure 2) were 
greater (P<0.05) among HA hens at 6, 5, 4, 3, 2, and 1 hours prior to 
oviposition (Figure 1 ). 
In Vitro Steroid Secretion 
Similar to plasma levels, in vitro progesterone production was higher 
(P<0.05) among HA hens as compared to LA hens. This was apparent in all 
follicle sizes at both 16 and 3 7 weeks of egg production (Table 5). 
Progesterone production by granulosa cells from both genetic lines was less 
(P<0.05) at 37 weeks of egg production, as compared to 16 
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Figure 1. Plasma progesterone (ng/ml) during one ovulatory cycle in HA and LA hens. 
(combined data from samples collected at 14 and 35 weeks of egg production). 
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Figure 2. Plasma luteinizing hormone (ng/ml) during one ovulatory cycle in HA and LA hens 
(combined data from samples collected at 14 and 35 weeks of egg production). 
*Indicates significant difference (P::::0.05). 
Table 5. In vitro progesterone and pregnenolone (P4 and PS; ng/ml) 
secretion from granulosa cells of the 3 largest preovulatory follicles (F 1,F 2, 
and F 3) from HA and LA hens at 16 and 37 weeks of egg production.* 
Weeks of Egg Production 
1§ 37 
Genetic Line/(number of hens) Genetic Line/(number ofhens) 
Steroid/Follicle 
Size HA/{n=20} LA/{n=20} HA/{n=20} LA/{n=20} 
P4(ng/ml)/ 
242.35 ± 3.69 Atat F1 follicle 191.57 ± 3.35 Ab 189.89 ± 3.69 Be 147.52 ± 3.41 Bd 
F2 follicle 148.25 ± 2.08 Be 141.24 ± 2.13 Bd 271.75 ± 2.21 Aa 164.86 ± 2.13 Ab 
F3 follicle 129.86 ± 1.53 Cb 95.53 ± 1.55 Cc 152.62 ± 1.46 Ca 65.31 ± 1.53 Cd 
P5 (ng/ml)/ 
12.70 ± 0.16 Aab F1 follicle 12.51 ± 0.14 Aa 12.24 ± 0.16 Bb 9.92 ± 0.14 Ac 
F2 follicle 10.35 ± 0. 10 Bb 9.01 ± 0.10 Bd 15.02 ± 0.11 Aa 9.92 ± 0.10 Ac 
F3 follicle 8.24 ± 0.08 Cb 6.30 + 0.08 Cc 10.90 + 0.08 Ca 6.07 + 0.08 Bd 
*Values are reported as least square means± standard error of the mean. Significant differences 
(P~0.05) are denoted by letter differences between the means oflog transformed data. 
tA,B,CValues within the same column and for the same steroid with different letters are 
significantly different (P~0.05). 
t,b,c,dValues within the same row with different letters are significantly different (P~0.05). 
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weeks of egg production. However, progesterone secretion was higher in F2 
follicles among both lines at 3 7 weeks of age (P<0.05). 
Similar differences were found in the production of pregnenolone by 
granulosa cells of HA and LA hens (Table 5). Pregnenolone secretion by 
granulosa cells was greater (P<0.05) among HA hens in all follicle sizes and 
in both time periods with the exception that F 1 follicle secretion was the 
same at 16 weeks of egg production. As would be expected, pregnenolone 
production was less (P<0.05) among the smaller pre-ovulatory follicles (F2 
and F3) as compared to the F1• However, as the hen aged, pregnenolone 
secretion was found to remain the same (F 1 follicle in HA and LA hens; 
P>0.05) or increase (F2 and F3 follicles in LA hens; P<0.05). 
Steroid Secretion as Affected by TNFa. 
In vitro treatment of granulosa cells with recombinant TNFa had 
little effect on basal progesterone secretion. Treatment off 1 and F3 follicles 
with hTNFa, but not mTNFa, resulted in a reduction (P<0.05) in 
progesterone secretion (Table 6). This decrease was evident in F 1 follicles 
among HA hens at 16 weeks of egg production and LA hens at 3 7 weeks of 
egg production. Similarly, progesterone production was reduced (P<0.05) 
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Table 6. In vitro progesterone (ng/ml) production from granulosa cells of 
the Fi, F2, and F3 follicles in HA and LA hens at 16 and 37 weeks of egg 
production in response to various treatments. 
Weeks of Egg Production 
16 37 
Genetic Line/(number of hens) Genetic Line/(number of hens) 
Follicle Size/freatment HA/(n=20) LA/(n=20) HA/(n=20) LA/(n=20) 
FI follicle/ 
Control (nothing) 123.65 c•at 90.46 Db 59.89 De 56.05 Cc 
hTNF (5 ng/ml) 107.31 Da 96.54 CDa 61.58 Db 46.77 De 
mTNF (5 ng/ml) 121.78 Ca 100.51 Cb 60.61 De 46.73 Dd 
oLH (100 ng/ml) 330.57Ba 273.33 Bb 311.03 BCb 217.68 Be 
oLH+hTNF 325.88Ba 284.62 ABb 293.30 Cb 224.34 Be 
oLH+mTNF 444.89Aa 303.95 Ab 352.91 Ab 293.59 Ab 
Pooled SEMl 3.69 3.35 3.69 3.41 
F2 follicle/ 
Control (nothing) 91.70 Cb 80.55 Cc 110.34 Da 79.12 De 
hTNF (5 ng/ml) 89.93 Cb 78.81 Cc 104.83 Da 82.63 CDb 
mTNF (5 ng/ml) 92.30 Cb 81.24 Cc 117.75Da 84.96 Cbc 
oLH (100 ng/ml) 188.82 Be 206.65 ABc 378.78 Ca 238.29 Bb 
oLH+hTNF 194.33 Be 192.99 Be 431.72 Ba 235.48 Bb 
oLH+mTNF 232.42 Ac 207.99 Ad 487.10 Aa 268.71 Ab 
Pooled SEM 2.08 2.13 2.21 2.13 
F 3 follicle/ 
Control (nothing) 81.62 Ca 59.83 Bb 58.63 Cb 35.99Bc 
hTNF (5 ng/ml) 80.31 Ca 55.58 Cb 56.64 Cb 33.22 Cc 
mTNF (5 ng/ml) 82.19 Ca 54.84 Cc 59.73 Cb 33.76 Cd 
oLH (100 ng/ml) 171.04 Bb 127.20Ac 234.61 Ba 95.32 Ad 
oLH+hTNF 174.87 Bb 140.93 Ac 232.35 Ba 96.33 Ad 
oLH+mTNF 189.16 Ab 134.80 Ac 273.75 Aa 97.21 Ad 
Pooled SEM 1.53 1.55 1.46 1.53 
*A,B,C,DValues in the same column and for the same follicle size with different letters are significantly 
different (P::::0.05). 
t a,b,c,dValues in the same row with different letters are significantly different(P::::0.05). 
tStandard error of the mean. 
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in F 3 follicles among LA hens at both time periods. Human TNF a. had no 
effect (P>0.05) on progesterone secretion from F2 granulosa cells, 
regardless of genetic line or age. 
Treatment of granulosa cells with oLH resulted in a large increase 
(P<0.05) in progesterone secretion which was further increased (P<0.05) 
after co-treatment with mTNFa. (Table 6), however this effect was lost in F3 
LA follicles. Co-treatment of granulosa cells with hTNFa. and oLH did not 
(P>0.05) result in an additive increase in progesterone secretion over that 
observed with oLH alone. 
As observed with progesterone secretion, in vitro pregnenolone 
secretion declined in response to treatment with hTNFa., but not mTNFa. 
(Table 7). This effect was more consistent among younger versus older 
hens, HA versus LA hens, and in larger follicles (F1 vs. F2 and F3). 
Pregnenolone secretion was less (P<0.05) after exposure to h1NFa. in F 1 
follicles among HA hens at 16 weeks of egg production, and LA hens at 3 7 
weeks of egg production. Similarly, less (P<0.05) pregnenolone was 
produced by F 2 granulosa cells from HA hens at both time periods, and F 3 
granulosa cells from both lines at 16 weeks of egg production in response to 
treatment with h TNF a.. 
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Table 7. In vitro pregnenolone (ng/ml) production from granulosa cells of 
the Fi,F2, and F3 follicles in HA and LA hens at 16 and 37 weeks of egg 
production in response to various treatments. 
Weeks of Egg Production 
1.§ 37 
Genetic Line/(number of hens) Genetic Line/(number of hens) 
Follicle Size/freatment HA/(n=20) LA/(n=20) HA/(n=20) LA/(n=20) 
F1 follicle/ 
Control (nothing) 732 C*at 6.65 Cb 6.22 CDb 5.48 Cc 
hTNF (5 ng/ml) 6.87Da 6.60 Ca 5.89Db 4.53 De 
mTNF (5 ng/ml) 6.94 Da 6.89 Ca 6.40 Ca 5.15 Cb 
oLH (100 ng/ml) 17.11 Bb 17.23 Bab 18.30 Aba 13.73 Be 
oLH+hTNF 17.75 Ba 18.14 Aba 17.52 Ba 14.03 Bb 
oLH+mTNF 20.14 Aa 19.54 Aa 19.13 Aa 16.60 Ab 
Pooled SEMt 0.16 0.14 0.16 0.14 
F2 follicle/ 
Control (nothing) 7.14 Cb 5.79 Cd 7.95 Da 6.34 Cc 
hTNF (5 ng/ml) 6.67 Db 5.50 Cd 7.42 Ea 6.16 Cc 
mTNF (5 ng/ml) 7.00 CDb 5.55 Cd 7.96 Da 6.19 Cc 
oLH (100 ng/ml) 13.27 Bb 12.09 Be 20.79 Ca 13.47 Bb 
oLH+hTNF 13.60 ABb 12.13 Be 21.93 Ba 13.21 Bb 
oLH+mTNF 14.45 Ab 12.98 Ac 24.07 Aa 14.16 Ab 
PooledSEM 0.10 0.10 0.11 0.10 
F 3 follicle/ 
Control (nothing) 5.94 Ca 4.80 Bb 5.99 Ca 4.11 Be 
hTNF (5 ng/ml) 5.23 Db 4.49 Cc 5.72 Ca 4.05 Bd 
mTNF (5 ng/ml) 5.78 Ca 4.89 Bb 5.79 Ca 4.17 Be 
oLH (100 ng/ml) 10.80 ABb 7.75 Ac 15.18 Ba 8.15 Ac 
oLH+hTNF 10.60 Bb 8.07 Ac 16.10 Aa 7.81 Ac 
oLH+mTNF 11.06 Ab 7.78 Ac 16.61 Aa 8.12 Ac 
PooledSEM 0.08 0.08 0.08 0.08 
*A,B,C,DValues in the same column and for the same follicle size with different letters are significantly 
different (P,:S0.05). 
ta,b,c,dy alues in the same row with different letters are significantly different {P,:::0.05). 
tStandard error of the mean. 
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Similar to the effect on progesterone secretion, treatment of granulosa 
cells with oLH resulted in a large increase (P<0.05) in pregnenolone 
secretion (Table 7). Co-treatment of granulosa cells with mTNFa and oLH 
caused a further increase (P<0.05) in pregnenolone secretion over that of 
oLH alone in all preovulatory follicles. This increase was predominant 
among F 1 and F 2 follicles, regardless of genetic line or age. F 3 follicles 
were basically unresponsive (P>0.05) to co-treatment with oLH and either 
mouse or human TNFa. The significant increase (P<0.05) in pregnenolone 
secretion due to oLH was not changed by addition of either form of the 
cytokine. 
Steroid Secretion as Affected by TNFa. During the Ovulatory Cycle 
Fl follicles: 
Analysis of data by time-point during the ovulatory cycle showed that 
the effect of TNF a on basal progesterone secretion of granulosa cells from 
young hens tended to occur very early ( 4 hrs) or very late (24 hrs) after 
oviposition of the previous egg {Table 8). The decline (P<0.05) in 
progesterone secretion evident in HA hens (as described in Table 6) was 
due to a reduction at 4 and 24 hours after oviposition. LA hens appeared to 
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Table 8. In vitro progesterone and pregnenolone production (ng/ml) by granulosa cells of the F1 follicle at 4, 12, 
18, and 24 hours after oviposition !11 HA_and LA hens at 16 weeks of egg production. 
Genetic Line 
HA LA 
Hours after Oviposition/(number of hens) Hours after Oviposition/(number of hens) 
Steroidffreatment 4/(n=S) 12/(n=S) 18/(n=S) 24/(n=5) 4/(n=5) 12/(n=S) 18/(n=5) 24/(n=5) 
Progesterone (ng/ml)/ 
Control (nothing) 138.10 c•at 147.03 Ca 161.94 Ca 47.55 Be 71.72 Bd 97.93 Bbc 108.99 Cb 83.17 Bed 
hTNF (5 ng/ml) 114.63 Db 135.39 Ca 143.53 Ca 35.69 Cd 81.39 Be 89.85 Be 126.84 BCab 88.07 Be 
mTNF (5 ng/ml) 134.02 CDb 142.52 Cab 166.73 Ca 43.83 Be 75.80 Bd 88.37 Be 146.17 Bab 91.69 Be 
oLH (100 ng/ml) 327.00 Be 315.35 Be 564.96 Ba 114.98 Ae 135.79 Ae 303.89 Ac 444.22 Ab 209.42 Ad 
w oLH+ hTNF 318.33 Bb 361.90 Bb 506.78 Ba 116.50 Ad 136.80 Ad 334.51 Ab 442.85 Aa 224.31 Ac 0\ 
oLH+mTNF 458.65 Ab 49l.l2 Ab 693.32 Aa 136.47Ae 148.71 Ae 330.86 Ac 495.34 Ab 240.90 Ad 
Pooled SEMt 6.86 7.02 6.70 8.73 6.70 6.86 6.53 6.70 
Pregnenolone (ng/ml)/ 
6.90 Cc 6.64 Cc 11.34 Ca 4.65 Ce 5.32 Cd 5.25 Bd 6.99 Cc 9.04 Bb Control (nothing) 
hTNF (5 ng/ml) 6_52 CDed 6.22 Cd 10.89 Ca 3.84 Cf 6.00 BCd 5.19 Be 7.31 Cbc 7.91 Cb 
mTNF (Sng/ml) 5.95 Dd 5.99 Cd l l.60 Ca 4.22 Cf 6.13 Bed 4.89 Be 7.19 Cc 9.34 Bb 
oLH (lOOng/ml) 14.33 Be 13.50 Be 31.42 Ba 9.19 Bd 11.l l Ad 13.35 Ac 22.69 Bb 21.76 Ab 
oLH+hTNF 15.28 ABe 13.75 Bed 31.l l Ba 10.86 Ae l l.84 Ade 14.09 Ac 21.89 Bb 24.73 Ab 
oLH+mTNF 16.93 Ac 16.40 Ac 36.62 Aa 10.62 Ad 11.40 Ad 15.07 Ac 27.20 Ab 24.50 Ab 
Pooled SEM 0.29 0.30 0.29 0.38 0.29 0.29 0.29 0.29 
*A,B,C,DValues in the same column and for the same steroid with different letters are significantly different (P:s;0.05). 
ta,b. · rValues in the same row with different letters are significantly different (P:s;0.05). 
tStandard Error of the Mean. 
be unresponsive to either form of TNFa.. The one exception was that 
mTNFa. caused an increase (P<0.05) in progesterone secretion 18 hours 
after oviposition. 
The increased (P<0.05) progesterone production after co-treatment of 
F1 granulosa cells with mTNFa. and oLH was found to occur 4, 12, and 18 
hours after oviposition in young HA hens {Table 8). LA hens were found to 
be unresponsive to co-treatment with oLH and mTNFa.. Ovine LH induced 
progesterone secretion from F 1 follicles of younger hens from each genetic 
line was not affected by co-treatment with hTNFa.. 
Analysis of pregnenolone data obtained during the ovulatory cycle 
showed that the hTNFa. induced decrease (P<0.05) occurred 4 hours after 
oviposition in HA hens, and 4 and 24 hours after oviposition in LA hens 
{Table 8). 
The addition of mTNFa. (but not hTNFa.) plus oLH consistently 
stimulated the production of pregnenolone by F 1 granulosa cells over that of 
oLH alone, throughout the ovulatory cycle in younger hens from both lines 
{Table 8). This was significant in HA hens at all times during the ovulatory 
cycle, and in LA hens 18 hours after oviposition. 
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Among older hens, the time response to TNFa was not observed in 
either genetic line with few exceptions (Table 9). Progesterone secretion 
increased (P<0.05) after exposure to hTh"'Fa in HA hens 12 hours after 
oviposition. In LA hens, 24 hours after ovipostion, both forms of TNFa 
reduced (P<0.05) F 1 follicle progesterone secretion. 
As in younger hens, granulosa cells from F 1 follicles of older hens co-
treated with mTNFa (but not hTNFa) and oLH consistently produced more 
(P<0.05) progesterone throughout the ovulatory cycle than cells treated with 
oLH alone (Table 9). Co-treatment resulted in higher (P<0.05) progesterone 
secretion at 4 and 18 hours after oviposition in HA hens, and 4, 12, and 24 
hours after ovipostion in LA hens. 
Differences in pregnenolone production due to in vitro treatment of 
F1 granulosa cells in older hens with hTNFa appeared to be dependent on 
genetic line (Table 9). While treatment with hTNFa suppressed (P<0.05) 
pregnenolone production at all times during the ovulatory cycle in LA hens, 
no effect (P>0.05) was seen in HA hens, regardless of time. As expected, 
mouse TNFa had no effect {P>0.05) on the secretion of pregnenolone at any 
time during the ovulatory cycle in either genetic line. 
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Table 9. In vitro progesterone and pregnenolone production (ng/ml) by granulosa cells of the F 1 follicle at 4, 12, 
18, and 24 hours after oviposition in HA and LA hens at 37 weeks of!_gg production. 
Genetic Line 
HA LA 
Hours after Oviposition/(number of hens) Hours after Oviposition/(number of hens) 
Steroidffreatment 4/(n=S) 12/(n=S) 18/(n=S) 24/(n=S) 4/(n=S) 12/(n=S) 18/(n=S) 24/(n=S) 
Progesterone (ng/ml)/ 
Control (nothing) 5239 C'bct 48.80 De 63.26 Cab 75.12Ba 37.91 Cd 60.38 Cb 56.33 Bbc 69.58 Cab 
hTNF (S ng/ml) 54.22 Cb 57.99 Cb 60.53 Cab 73.58 Ba 38.44 Cc 52.85 Cbc 50.49 Bbc 45.29 De 
mTNF (S ng/ml) 50.01 Cbc 61.29 Cab 58.11 Cb 73.01 Ba 37.09 Cd 53.26 Cbc 49.67 Bbc 46.88 De 
oLH (100 ng/ml) 128.94 Be 638.54 ABa 167.06 Bd 309.57 Ab 232.45 Be 300.75 Bb 157.77 Ad 179.74 Bd 
v,J oLH+ hTNF 139.19 ABd 586.28 Ba 182.51 Be 265.23 Ab 257.68 Bb 279.08 Bb 149.55 Ad 211.04 Be \0 
oLH+mTNF 152.68 Ae 735.94 Aa 231.06 Ad 291.97 Ac 329.45 Abe 372.27 Ab 141.90 Ae 330.28 Abe 
Pooled SEMt 6.70 6.53 7.02 8.98 6.53 6.70 6.70 7.34 
Pregnenolone (ng/ml)/ 
6.21 Ba 6.10 Cab 6.36 Cab 6.23 Cab 4.57 Cc 5.44 Bb 6.12 Bab 5.78 Cab Control (nothing) 
hTNF (Sng/ml) 5.96 Bab 6.19 Ca 5.53 Cab 5.87 Cab 3.85 De 4.37 Cc 5.22 Cb 4.67 Dbc 
mTNF (Sng/ml) 6.61 Ba 7.03 Ba 6.02 Cc 5.93 Ced 4.86 Cd 5.04 Bd 5_60 BCcd 5.09 CDd 
oLH (l00ng/ml) 11.48 Ac 28.65 Aa 16.05 ABb 17.03 ABb 15.74 Bb 16.69 Ab 11.37 Ac 11.llBc 
oLH+hTNF 11.98 Ac 27.74 Aa 14.91 Bbc 15.45 Db 15.87 Bb 16.15 Ab 12.05 Ac 12.04 Be 
oLH+mTNF 12.58 Ac 28.65 Aa 16.84 Ab 18.47 Ab 18.63 Ab 18.07 Ab 11.88 Ac 17.82 Ab 
Pooled SEM 0.29 0.28 0.29 0.38 0.29 0.27 0.29 0.30 
*A,B,C,DValues in the same column and for the same steroid with different letters are significantly different (P~0.05). 
ta,b ... fValues in the same row with different letters are significantly different (P~0.05). 
+Standard error of the mean. 
Pregnenolone production by F 1 granulosa cells was further increased 
(P<0.05) over that of oLH alone in response to co-treatment with m1NFa in 
LA, but not HA, hens at 37 weeks of egg production (Table 9). 
Specifically, these cells secreted more (P<0.05) pregnenolone 4 and 24 
hours after ovipostion. 
F2follicles: 
Basal production of progesterone by F2 granulosa cells measured at 4, 
12, 18, or 24 hours after oviposition was unaffected (P>0.05) by treatment 
with either form of TNFa with one exception(Tables 10 and 11 ). As with 
F 1 follicles, F2 progesterone secretion was less (P<0.05) 4 hours after 
oviposition among older HA hens in response to hTNFa. 
In vitro treatment of F2 follicles with mTNFa and oLH consistently 
resulted in higher (P<0.05) progesterone secretion as compared to treatment 
with oLH alone among hens of both genetic lines and at either age (Tables 
10 and 11). This was most evident in HA versus LA hens (Table 10). 
Basal pregnenolone secretion was only reduced (P<0.05) after 
treatment with hTNFa 12 hours after oviposition in either genetic line at 16 
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Table 10. In vitro progesterone and pregnenolone production (ng/ml) by granulosa cells of the F2 follicle at 4, 
12, 18, and 24 hours after oviposition in HA and LA hens at 16 weeks_of egg production. 
Genetic Line 
HA LA 
Hours after Oviposition/(number of hens) Hours after Oviposition/(number of hens) 
Steroidffreatment 4/(n=S) 12/(n=S) 18/(n=S) 24/(n=S) 4/(n=S) 12/(n=S) 18/(n=S) 24/(n=S) 
Progesterone (ng/ml)/ 
Control (nothing) 97.84 C*bt 100.17 Cb 131.20 Ca 37.59 Ce 49.78 Cd 95.77 Bb 117.71 Ba 58.93 Be 
hTNF (S ng/ml) 98.26 Cc 100.49 Cbc 122.92 Ca 38.05 Ce 50.60 Cd 98.60 Bbc 114.20 Bab 51.83 Bd 
mTNF (S ng/ml) 100.22 Cb 101.30 Cb 129.41 Ca 38.26 Cd 52.69 Cc 91.62 Bb 126.64 Ba 54.01 Be 
oLH (100 ng/ml) 192.93 Be 195.66 Be 273.05 Bb 93.61 Be 123.37 Bd 186.59 Ac 400.53 Aa 116.08 Ad 
.I:>, oLH+hTNF 197.09 Be 222.25 ABbc 253.74 Bb 104.26 ABd 112.23 Bd 203.09 Ac 343.14 Aa 110.42 Ad .... 
oLH+mTNF 239.79 Abe 245.60 Ab 329.46 Aa 114.82 Ae 141.45 Ad 209.29 Ac 373.53 Aa 07.71 Ae 
Pooled SEMt 4.21 4.21 4.00 4.21 4.32 4.42 4.32 4.00 
Pregnenolone (ng/ml)/ 
6.90 Cc 6.97 Be 9.71 Ba Control (nothing) 4.99 Be 3.91 Bf 5.85 CDd 8.41 Bb 5.00 Ce 
hTNF (S ng/ml) 6.33 Cc 5.80 Ced 9.65 Ba 4.91 Bd 4.29 Be 5.36 Dd 7.25 Cb 5.11 Cd 
mTNF (5 ng/ml) 6.73 Cbc 6_51 BCbc 9.61 Ba 5.14 Bd 4.25 Be 6.07 Cc 7.25 Cb 4.63 Cd 
oLH (100 ng/ml) 12.67 Bed 11.76 Ad 19.48Aa 9.16 Ae 9.99 Ac 13.64 Be 16.36 Ab 8.37 ABe 
oLH+hTNF 12.56 Be 12.82 Ac 19.02 Aa 9.98 Ad 10.80 Ad 13.65 Be 15.92 Ab 8.14 Be 
oLH+mTNF 14.03 Abe 13.02 Ac 20.82 Aa 9.93 Ade 11.45 Ad 15.75 Ab 15.60 Ab 9.13 Ae 
Pooled SEM 0.20 0.22 0.20 0.21 0.19 0.21 0.21 0.20 
*A,B,C,DValues in the same column and for the same steroid with different letters are significantly different (P!>0.05). 
t3,b ... rValues in the same row with different letters are significantly different (P!>0.05). 
tStandard error of the mean. 
Table 11. In vitro progesterone and pregnenolone production (ng/ml) by granulosa cells of the F2 follicle at 4, 
12, 18, and 24 hours after oviposition in HA and LA hens at 37 weeks of egg production. 
Genetic Line 
HA LA 
Hours after Oviposition/(number of hens) Hours after Oviposition/(number of hens) 
Steroidffreatment 4/(n=S) 12/(n=S) 18/(n=S) 24/(n=S) 4/(n=S) 12/(n=5) 18/(n=S) 24/(n=S) 
Progesterone (ng/ml)/ 
Control (nothing) 7630 c•cdt 197.71 Da 98.03 Cb 69.35 Bd 40.00 Ce 79.85 Cc 104.51 Bb 92.13 Bb 
hTNF (5 ng/ml) 65.08 Dd 187.56 Da 97.19 Cb 69.49 Bd 48.68 Ce 80.91 Cc 103.33 Bb 97.61 Bb 
mTNF (5 ng/ml) 74.49 CDd 214.96 Da 106.91 Che 74.66 Bd 48.03 Ce 87.81 Cc 109.72 Bb 94.26 Be 
oLH (100 ng/ml) 226.99 Bd 679.54 Ca 179.05 Be 429.52 Ab 146.15 Bf 258.79 Bd 312.79 Ac 235.42 Ad 
oLH+hTNF 256.29 ABcd 830.86 Ba 230.20 Ad 409.53 Ab 158.31 Be 279.30 ABc 277.68 Ac 226.64 Ad 
~ oLH+mTNF 275.45 Acd 969.65 Aa 233.79 Ae 469.51 Ab 206.16Ae 311.26 Ac 313.14 Ac 244.26 Ad N 
Pooled SEMt 4.32 4.61 4.42 4.32 4.32 4.32 4.21 4.21 
Pregnenolone (ng/ml)/ 
Control (nothing) 5.85 Be I 0.47 Ba 8.82 Cb 6.65 Ced 4.43 Bf 6.45 Cd 7.40 Be 7.07 Bed 
hTNF (5 ng/ml) 5.59 Be 9.82 Ba 8.18 Cb 6.10 Cc 4.67 Bd 5.94 Cc 7.96 Bb 6.08 Cc 
mTNF (5ng/ml) 6.IOBd 10.78 Ba 8.46 Cb 6.52 Cd 4.38 Be 6.08 Cd 7.54 Bbc 6_77 Bed 
oLH (100 ng/ml) 17.07 Ac 31.02 Aa 14.lOBd 20.99 Bb 11.72 Ae !3.2 I Bde 15.87 Ac 13.06 Ade 
oLH+hTNF 17.08 Ac 31.81 Aa 16.54 Acd 22.30 Bb 11.64 Ae 13.69 Bde 15.07 Ad 12.44 Ae 
oLH+mTNF 17.05Acd 34.65 Aa 18.24 Ac 26.34 Ab 11.78 Af 15.63 Ad 15.92 Ad 13.31 Ae 
Pooled SEM 0.21 0.21 0.21 0.22 0.22 0.22 0.20 0.20 
*A,B,C,DValues in the same column and for the same steroid with different letters are significantly different (P:':0.05). 
ta,b ... fValues in the same row with different letters are significantly different (Ps0.05). 
tStandard error of the mean. 
weeks of egg production {Tables 10 and 11). As before, mTNFa had no 
effect (P>0.05) on basal secretion ofpregnenolone. 
Co-treatment of F2 granulosa cells with a combination of either 
mTNFa or hTNFa and oLH did not increase (P>0.05) F2 follicle 
pregnenolone production from hens of either genetic line with few 
exceptions {Tables 10 and 11). Pregnenolone secretion was higher (P<0.05) 
among younger HA hens 4 hours after ovipostion, and 18 and 24 hours after 
oviposition in older HA hens after in vitro treatment with mTNFa and oLH. 
In LA hens of both ages, pregnenolone production increased (P<0.05) 12 
hours after oviposition in response to co-treatment with mTNFa plus LH. 
F3 follicles: 
Only isolated effects on F 3 follicle progesterone production were 
observed due to treatment with hTNFa {Tables 12 and 13). Reduced 
(P<0.05) progesterone production was observed in HA hens 4 hours after 
oviposition at both 16 and 3 7 weeks of egg production. F 3 follicle 
progesterone secretion was less (P<0.05) among LA hens 4 hours after 
oviposition at 16 weeks of egg production, and 18 hours after oviposition at 
both ages. Treatment ofF3 follicles from younger LA hens with mTNFa 
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Table 12. In vitro progesterone and pregnenolone production (ng/ml) by granulosa cells of F3 follicles at 4, 12, 
18, and 24 hours after oviposition in HA and LA hens at 16 weeks of llgg production. 
Genetic Line 
HA LA 
Hours after Oviposition/(number of hens) Hours after Oviposition/(number of hens) 
Steroidffreatment 4/(n=S) 12/(n=S) 18/(n=S) 24/(n=S) 4/(n=S) 12/(n=S) 18/(n=S) 24/(n=S) 
Progesterone (ng/ml)/ 
Control (nothing) 78.61 C*ct 86.34 Cbe 127.08 Ba 34.45 CDe 37.26 Be 56.48 Cd 92.98 Cb 52.58 Bd 
hTNF (S ng/ml) 67.45 Dd 93.64 Cb 123.07 Ba 37.08 Cf 31.88 Cg 59.84 BCd 78.30 De 52.30 BCe 
mTNF (S ng/ml) 72_20 CDcd 90.30 Cb 135.95 Ba 30.31 Df 30.99 Cf 64.39 Bd 77.62 De 46.36 Ce 
oLH (100 ng/ml) 195.86 Bb 206.02 Bb 242.95 Aa 39.32 Bf 117.61 Ad 143.51 Ac 156.47 Be 91.21 Ae 
.J::- oLH+hTNF 218.37 ABa 207.72 Ba 230.66 Aa 42.74 ABe 121.27 Ac 148.44 Ab 204.18 Aa 89.80 Ad .J::-
oLH+mTNF 242.67 Aa 235.67 Aa 229.97 Aa 48.32 Ae 125.05 Ac 154.60 Ab 171.08 Bb 88.46 Ad 
Pooled SEMt 2.89 2.82 3.17 3.30 2.82 2.89 3.66 2.96 
Pregnenolone (ng/ml) 
5.27 Be 5.48 Cbc 8.60 Ba 4.39 Cd 3.86 Be 4.92 Bed 5.97 Cb 4.45 Bd Control (nothing) 
hTNF (Sng/ml) 4.66 Ced 4.84 De 7.96 Ba 3.47 De 3.23 Ce 4.23 Cd 6.40 BCb 4.10 BCd 
mTNF (S ng/ml) 5.52 Be 5.27 CDc 8.54 Ba 3.80 De 4.29 Bde 4.62 BCd 6.68 Db 3.98 Ce 
oLH (100 ng/ml) 11.55 Ab 10.42 Bbc 16.00 Aa 5.25 Ag 7.11 Be 8.00 Ad 9.65 Ac 6.24 Af 
oLH+hTNF 11.39 Ab 11.38 ABb 15.21 Aa 4.41 Be 8.07 Ac 7.78 Ac 10.42 Ab 6.01 Ad 
oLH+mTNF 12.24 Ab 11.76 Ab 15.22 Aa 5.01 Af 6.92 Bde 7.36 Ad 10.42Ac 6.41 Ae 
Pooled SEM 0.15 0.16 0.16 0.19 0.15 0.15 0.19 0.15 
*A,B,C,DValues in the same column and for the same steroid with different letters are significantly different (Ps;0.05). 
ta,b ... gValues in the same row with different letters are significantly different (PS:0.05). 
tStandard error of the mean. 
Table 13. In vitro progesterone and pregnenolone production (ng/ml) by granulosa cells of F3 follicles at 4, 12, 
18 and 24 hours after oviposition in HA and LA hens at 37 weeks of egg production. 
Genetic Line 
HA LA 
Hours after Oviposition/(number of hens) Hours after Oviposition/(number of hens) 
Steroidffreatment 4/(n=5) 12/(n=5) 18/(n=5) 24/(n=5) 4/(n=5) 12/(n=5) 18/(n=5) 24/(n=5) 
Progesterone (ng/ml)/ 
Control (nothing) 54_72 C*bct 71.20 Da 57.40 Be 57.18 Cbc 12.50 Be 60.59 Bb 33.88 Bd 37.00 BCd 
hTNF (5 ng/ml) 44.98 De 70.85 Da 54.28 Bb 56.45 Cb 11.44 Bf 53.95 Bb 28.23 Ce 39.27 Bd 
mTNF (5 ng/ml) 48.37 De 80.24 Ca 57.24 Bb 53.05 Cbc 12.00 Be 56.85 Bb 32.72 Bd 33.46 Cd 
oLH (100 ng/ml) 182.79 Bb 325.81 Ba 98.22 Ad 331.60 Ba 50.62 Ae 115.58Ac 102.62 Acd 112.46 Ac 
oLH+hTNF 162.18 Be 300.25 Bb 99.73 Ac 362.25 Ba 54.33 Af 114.22 Ad 91.65 Ae 125.12 Ad 
~ oLH+mTNF 210.78 Ab 366.86 Aa 107.47 Ad 409.90 Aa 51.98 Af 127.98 Ac 94.78 Ae 114.llAcd Vl 
Pooled SEMt 2.89 2.75 3.03 2.96 2.82 3.30 3.17 2.89 
Pregnenolone (ng/ml)/ 
Control (nothing) 5.40cc 6.86 Ba 5.68 Cbc 6.01 Cb 2.53 CDe 5.13 Be 4.56 Cd 4.23 Bd 
hTNF (5 ng/ml) 5.38 Cb 6.69 Ba 5.25 Cb 5.56 Cb 2.42 Dd 5.51 Bb 3.96 De 4.32 Be 
mTNF (5 ng/ml) 5.34 Cbc 7.44 Ba 5.51 Cb 4.87 De 2.78 Cd 5.39 Bbc 4.28 CDc 4.22 Be 
oLH (100 ng/ml) 12.40 Bb 19.78Aa 9.96 ABc 18.57 Ba 6.46 Ae 9.40 Acd 8.64 Ad 8.10 Ad 
oLH+hTNF 13.15 Be 19.21 Ab 10.16Ad 21.87 Aa 5.94 ABg 9.16 Ade 7.52 Bf 8.61 Ae 
oLH+mTNF 14.68 Ab 20.42 Aa 9.16 Be 22.19 Aa 5.67 Be 9.95 Ac 8.01 ABd 8.87 Ac 
Pooled SEM 0.15 0.15 0.16 0.16 0.15 0.19 0.17 0.15 
*A,B,C,DValues in the same column and for the same steroid with different letters are significantly different (P::;0.05). 
ta,b gValues in the same row with different letters are significantly different (P::;0.05). 
tStandard error of the mean. 
reduced (P<0.05) progesterone secretion 4, 18, and 24 hours after 
oviposition. 
Co-treatment of F3 granulosa cells with mTNFa and oLH increased 
(P<0.05) progesterone production over that observed with oLH alone from 
HA, but not LA, hens as the ovulatory cycle progressed (Tables 12 and 13). 
This was evident at 4, 12, and 24 hours after oviposition in HA hens, 
regardless of age. 
The decrease m F3 pregnenolone secretion after treatment with 
hTNFa was primarily a result of lowered (P<0.05) steroid production in 
younger hens at 4, 12, and 24 hours after oviposition in HA hens, and 4 and 
12 hours after oviposition among LA hens (Tables 12 and 13). In older 
hens, this response to hTNFa was diminished and observed only in the LA 
line 18 hours after oviposition. Treatment of F 3 granulosa cells with 
mTNFa caused reduced (P<0.05) pregnenolone secretion 24 hours after 
oviposition among both lines at 16 weeks of egg production, and at the 
same time in HA hens at 3 7 weeks of egg production. 
The limited effect on pregnenolone secretion after co-treatment with 
mTNFa and oLH was found to occur early in the ovulatory cycle, and 
primarily in HA hens (Tables 12 and 13). Pregnenolone production in HA, 
46 
but not LA, hens increased (P<0.05) at 12 hours after oviposition in younger 
hens, and at 4 and 24 hours after oviposition in older hens. Interestingly, 
mTNFa and oLH caused a reduction (P<0.05) in pregnenolone production 
by F 3 granulosa cells from older LA hens 4 hours after oviposition. This 
was the only case in which the mTNFa and oLH treatment caused a 
decrease in either steroid (regardless of follicle size, age, or genetic line). 
Treatment of F3 granulosa cells with hTNFa and oLH decreased (P<0.05) 
pregnenolone secretion at 24 hours after oviposition in younger HA hens, 
and at 18 hours after oviposition in older LA hens. 
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4. DISCUSSION 
As reported previously, Single Comb White Leghorn hens, selected 
for their ability to respond to an immune challenge with SRBC's, are 
known to differ in fertility, growth rate, age at puberty, egg production, and 
ability to resist bacterial or viral infection (Hall et al., 1978; Gross et al., 
1980; Siegel and Gross, 1980; Siegel et al., 1982; Martin et al., 1990; 
Dunnington et al., 1991). Siegel et al. (1982) and Bryan et al. (1997) 
reported that LA hens reached puberty before HA hens ( 13 and 14 days 
respectively), and laid more (P<0.05) eggs to 300 days of age. In the 
current study, overall percent HDEP did not differ between genetic lines. 
However, both the date of puberty and 15% HDEP in hens of the LA line 
occurred 9 days prior to that of HA hens. Consequently, when percent 
HDEP to 442 days of age was measured, it was found that LA hens 
produced more (P<0.05) eggs than HA hens. Dunnington and Siegel 
( 1984) suggested that LA hens began to lay before HA hens simply because 
they attained the body weight necessary for reproduction at an earlier age. 
Serial sampling of blood plasma revealed that levels of circulating 
progesterone and luteinizing hormone were higher (P<0.05) among HA 
hens from the time of the preovulatory surge until ovulation. Given the 
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previously described differences between HA and LA hens, there may also 
exist a divergence in the levels and/or activities of certain enzymes within 
the steroid pathway. If these differences do exist, they could influence the 
production of steroids to the extent that the rate of egg production may be 
affected. Currently, the reason(s) for the differing levels of progesterone 
and luteinizing hormone between these genetic lines is unknown. 
At both 16 and 3 7 weeks of egg production, the ovary from HA hens 
weighed more (P<0.05) than that of LA hens. In older hens, this difference 
may be explained by the presence of larger (P<0.05) preovulatory follicles 
(F1-F3) and a greater (P<0.05) number of small, 1-6 mm follicles on the 
ovary. In younger hens, however, an explanation was not as forthcoming. 
At 16 weeks of egg production, only F2 follicles were larger (P<0.05) in 
HA hens. There were no differences in the numbers of 1-12 mm follicles 
among HA and LA hens at 16 weeks of egg production. So, some factor 
other than tissue weight is contributory to the higher steroid production 
associated with HA hens. 
The conversion of pregnenolone to androgens occurs via one of two 
different pathways. The Li 5 pathway involves the metabolism of 
pregnenolone to androstenedione (At) using dihydroepiandrostenedione 
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(DHEA) as an intermediary, while in the ~4 pathway, pregnenolone is 
converted to Ai through progesterone (Lee et al., 1998; Figure 3). A recent 
study showed that, although both avian granulosa and theca cells have 
functional ~4 and ~5 pathways, granulosa cells prefer the ~4 pathway, 
whereas theca cell steroidogenesis occurs mainly via the ~ 5 pathway (Lee et 
al., 1998). As the FI follicle matures, its ability to convert progesterone to 
androstenedione diminishes, due to a decrease in the activity of the P450 
17a.-hydroxylase/17,20 lyase enzyme complex (Robison and Etches, 1986). 
This inability of ovarian cells from the FI follicle to convert progesterone to 
Figure 3. The fl. 4 and fl. 5 steroidogenic pathways* t 
*CHOL: cholesterol; P5: pregnenolone; P4: progesterone; DHEA: dihydroepiandrosterone; ~: androstenedione; 
T2: testosterone; E2: estradiol-l 7P; P450scc: cholesterol side-chain cleavage enzyme; 3P-HSD: 3P-
hydroxysteroid dehydrogenase; P450cl 7: cytochrome P450 17a.-hydroxylase/l 7,20 lyase; P450arom: aromatase. 
tThis figure taken from Lee et al. ( 1998); Domestic Animal Endocrinology, 15: 1-8. 
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androstenedione leads to an accumulation of the former. Progesterone 
released from granulosa cells in the hen activates receptors present in the 
hypothalamus and anterior pituitary, inducing the release of LH 
(Kawashima et al., 1979). Luteinizing hormone, in turn, binds to 
receptors on the granulosa cells of preovulatory follicles, causing them to 
secrete more progesterone. This positive feedback loop culminates in 
preovulatory "spikes" ( or peaks) of progesterone and LH that occur 
approximately 6 hours prior to ovulation (Wilson and Sharp, 1973; 
Johnson and van Tienhoven, 1980). Therefore, it is possible that a 
decrease in progesterone could interfere with this positive feedback cycle, 
and ultimately delay or inhibit ovulation. 
The production of progesterone by granulosa cells increases as 
follicles mature. It is clear that much of the progesterone produced by 
granulosa cells from F 2 and F 3 follicles diffuses to the theca layer and is 
further metabolized to androgens or estrogen (Etches and Duke, 1984 ). 
Progesterone produced by F 1 follicle granulosa cells however is subject to 
no further modification, and is released into the peripheral circulation 
(Etches and Duke, 1984). In the current study, in vitro progesterone and 
pregnenolone production was higher among more mature preovulatory 
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follicles (F 1>F2>F3). However, at 37 weeks of egg production, F2 follicles 
produced more progesterone and pregnenolone than did F 1 follicles. This 
unexpected difference in steroid production may have resulted from the 
inadvertent addition of higher cell numbers to culture media. Analysis of 
total media protein did not explain differences in steroid secretion because 
of the relatively high amount of BSA added to the culture media as 
compared to total protein secreted by granulosa cells in the 3 hour 
incubation period. 
In the mammal, the effects ofTNFa. on ovarian steroidogenesis have 
been researched in detail. TNF a. has been shown to inhibit FSH induced 
steroid production, aromatase activity, and LH receptor number in 
undifferentiated granulosa cells of the rat (Emoto and Baird, 1988; Adashi 
et al., 1989; Darbon et al., 1989). Given these observations, it is possible 
that the cumulus phenotype (i.e. low aromatase, reduced LH binding, and 
decreased steroidogenic potential) is caused by ovarian TNFa in mammals, 
and tends to "spare" the follicle from premature differentiation. Terranova 
( 1997) suggested that one function of TNF a. may be to protect the 
undifferentiated oocyte from the adverse effects associated with estrogen. 
Butcher et al. (1975) reported that delayed ovulation, which is associated 
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with prolonged exposure to estrogen, increased abnormalities in oocytes. 
More over, FSH driven estrogen production and LH receptor formation are 
of critical importance if granulosa cells are to differentiate (Darbon et al., 
1989). Therefore, TNFa may be involved in the inhibition of this process 
in mammals. 
In mammalian granulosa cells that are undergoing or have undergone 
differentiation to luteal cells, the effects of 1NF a appear to be somewhat 
different. 1NF a has been shown to reduce LH stimulated progesterone 
production in the rat, pig, and cow, while stimulating the production of 
PGF2a (Velhuis et al., 1991; Benyo and Pate, 1992; Adashi et al., 1990; 
Branstromm et al., 1993; Pitzel et al., 1993). Therefore, it appears that 
1NFa may participate to some extent in luteal regression (Terranova et al., 
1995). 
There is very little information available concerning the effect of 
cytokines on ovarian steroidogenesis in the avian. Bryan et al. ( 1997) 
reported that in vitro progesterone was consistently reduced (P<0.05) 
below basal levels when granulosa cells from domestic hens were treated 
with a dose of 5 ng/ml h1NFa. 
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In this study, treatment of granulosa cells with human 1NF a 
decreased (p<0.05) basal progesterone production in F 1 and F3 follicles, 
and confirmed the report of Bryan et al. (1997). Similarly, basal 
pregnenolone secretion from all preovulatory follicles was reduced 
(P<0.05) in response to treatment with hlNFa. However, in most cases, 
preovulatory follicles appeared unresponsive to mouse TNFa, with few 
effects observed on basal progesterone and pregnenolone secretion. 
Johnson and van Tienhoven (1984) demonstrated a dose-dependent 
decrease of in vivo progesterone levels in response to injection with 
aminoglutethimide (a potent inhibitor of steroidogenesis). This reduction 
in progesterone resulted in the absence of either an LH surge or ovulation. 
The reintroduction (via injection) of progesterone resulted in a renewed 
preovulatory surge of LH, followed by ovulation of the F 1 follicle. While 
this is proof that a reduction in progesterone can inhibit ovulation, the 
threshold at which progesterone must fall below for this to occur is 
unknown. 
In order to determine the point during the ovulatory cycle when 
1NF a was affecting steroid secretion, a time-course study was conducted. 
Although hTNFa consistently caused a numerical reduction in basal 
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progesterone and pregnenolone secretion by granulosa cells, these 
differences were rarely significant (P<0.05). The lack of significance 
observed in the time-course study may have been due to small sample size 
(5 hens/time-point). As a result, no clear pattern emerged as to when 
specifically hTNFa was having its affect. 
It is well known that LH stimulates the production of progesterone 
from granulosa cells in the domestic hen (Hammond et al., 1980; Marrone 
and Hertelendy, 1983). Asem et al. (1983) determined that progesterone 
production by granulosa cells increased when cultured in the presence of 
ovine LH. In the current research, treatment of granulosa cells with oLH 
stimulated (P<0.05) progesterone production over basal levels without 
exception. 
In contrast to the effects ofhTNFa on basal progesterone production 
during the ovulatory cycle, there was indeed a clear and well defined 
response of granulosa cells when treated with mTNFa, but not hTNFa, in 
the presence of an ovulatory amount of oLH (100 ng/ml). Under these 
circumstances, the secretion of progesterone and pregnenolone increased 
( over that produced in response to treatment with oLH alone) among hens 
of both ages and genetic lines, in all follicle sizes, and at almost all times 
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during the ovulatory cycle. Co-treatment of granulosa cells with hTNFa 
and oLH did, occasionally, increase (P<0.05) progesterone and 
pregnenolone secretion over that of oLH alone. However, this was not as 
consistent as that observed after treatment with oLH and the murine form 
of TNFa. Branstrom et al. (1995) reported that co-treatment of perfused 
rat ovaries with hTNFa (40 ng/ml) and oLH (100 ng/ml) increased in vitro 
progesterone production as compared to treatment with oLH alone. 
Furthermore, they reported a four-fold increase in the rate of LH induced 
ovulatory rates when perfused ovaries were exposed to hTNFa. At this 
time, the significance of an increase in progesterone productions by 
granulosa cells in the hen is not known. Zolti et al. (1990) found that 
concentrations of TNFa in bovine follicular fluid increased as ovulation 
approached. This implies the possibility that, in the hen, TNFa may 
potentiate the LH induced production of progesterone as follicles mature, 
and thereby augment or at least influence the ovulatory process. 
Recently, Tartaglia and Goedde! (1992) proposed a model by which 
the 7 5 kDa type II receptor for TNF a could sequester TNF a and "pass it 
on" to the 55 kDa type I receptor. As discussed previously, the type II 
receptor has a greater affinity for TNFa than does the type I receptor. 
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However, TNFa. dissociates from the type II receptor at a greater rate than 
from the type I receptor, thereby facilitating interaction of the cytokine 
with the type I receptor (Medvedev et al., 1996). Since the type II receptor 
does not associate with human TNFa., this effect would only be observed 
when studying the murine form. Corroborating evidence for this "ligand 
passing" model comes from a study in which hTNFa. was considerably less 
effective than mTNFa in the induction of IL-6 in vitro and in vivo in the 
mouse (Benigni et al., 1996). However, when the authors injected 
antibodies to each receptor, they found that activation of the type I receptor 
was more effective in stimulating the production of IL-6. In fact, it 
appeared that the antibody to the type II receptor was absolutely incapable 
of inducing IL-6 production (Benigni et al, 1996). Recently, the type I 
receptor for TNFa has been implicated in the induction of HIV-1 
expression (Matsuyama et al., 1991 ). Butera et al. ( 1996) found no direct 
action of HIV-1 by the type II receptor. However, when the type II 
receptor was blocked (by antibodies), the effect of TNFa. on HIV-I 
induction was decreased markedly, suggesting to the authors that the type 
II receptor enhanced the binding of TNFa. to the type I receptor. There 
exists the possibility that this "ligand passing" model is applicable to the 
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increased in vitro production of progesterone by granulosa cells of the hen 
in response to m1NFa. and oLH. It should not, however, be ruled out that 
the effects ofm1NFa. and oLH on steroidogenesis in the laying hen are the 
result of a direct activation of the type II 1NFa. receptor. 
Future research should be aimed at the identification and 
localization, as well as the physiologic roles, of the 1NFa. receptors in the 
ovary of the laying hen. Finally, since these studies utilized only granulosa 
cells, it would be of great interest to study the effect(s) of 1NFa. on the 
intact follicle composed of theca and granulosa cells. 
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5. SUMMARY 
Single Comb White Leghorn hens, genetically selected for either high 
or low levels of antibody in response to an immune challenge with SRBC's, 
displayed different production characteristics. Low antibody hens reached 
sexual maturity approximately 9 days before HA hens, and laid more 
(P<0.05) eggs to 442 days of age. Analysis of in vivo steroid production 
showed that both progesterone and luteinizing hormone were higher 
(P<0.05) among HA hens during the 6 hours prior to ovulation. Although 
the reason( s) for these differences are currently unknown, they may be due 
to differences in the levels or activities of enzymes within the steroid 
pathway or differential tissue response to either gonadotropins or steroids. 
In vitro progesterone and pregnenolone production was generally 
higher (P<0.05) among HA hens as compared to LA hens, and in larger 
versus smaller preovulatory follicles. As in the mammal, TNFa appears to 
inhibit basal steroidogenesis in the laying hen. Treatment of granulosa cells 
with hTNFa, but not mTNFa resulted in reduced (P::::::0.05) progesterone and 
pregnenolone production. However, these decreases were not as prevalent, 
or of the magnitude of those previously reported by our laboratory (Bryan et 
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al., 1997). Conversely, in vitro treatment of granulosa cells with mTNFa in 
the presence of an ovulatory amount of oLH (100 ng/ml) consistently and 
markedly increased (P<0.05) the secretion of progesterone and 
pregnenolone over that observed after treatment with either oLH alone or 
hTNFa and oLH. 
The observation that co-treatment of granulosa cells with mTNFa and 
oLH stimulated steroid secretion over that produced in response to 
treatment with hTNFa and oLH suggests a role for the type II TNFa 
receptor in potentiating the effects of the type I TNFa receptor. However, 
since the intracellular domains of the two receptors share little or no 
sequence homology, it is unclear whether these differences in steroid 
production are the result of ligand passing, or a direct activation of the type 
II receptor. 
Due to the high incidence of exposure to microbial pathogens in 
commercial poultry operations, the study of the effects of cytokines on 
avian reproduction is of great importance. A better understanding of how 
these cytokines influence the reproductive cycle in the avian will allow for 
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